Camber Capital Management »

Qiagen Nv shares owned by Camber Capital Management

Quarter-by-quarter ownership of Qiagen Nv shares owned by Camber Capital Management from 13F filings

Historical chart of Camber Capital Management investment in Qiagen Nv

Tip: Access up to 7 years of quarterly data

All positions including Qiagen Nv held by Camber Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qiagen Nv by Camber Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $16M 400k 40.50
2022-12-31 $37M 750k 49.87

More positions owned by Camber Capital Management

Universal Hlth Svcs CL B (UHS)
Pfizer Call Option (PFE)
Tenet Healthcare Corp Com New (THC)
Zimmer Holdings (ZBH)
Viatris (VTRS)
Sanofi Sponsored Adr (SNY)
Medtronic SHS (MDT)
Walgreen Boots Alliance (WBA)
Baxter International (BAX)
Myriad Genetics (MYGN)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
GSK Sponsored Adr (GSK)
Ionis Pharmaceuticals (IONS)
Sarepta Therapeutics (SRPT)
Select Medical Holdings Corporation (SEM)

View all positions for Camber Capital Management

Top funds holding Qiagen Nv

Massachusetts Financial Services
Vanguard Group
Wellington Management Company
Amundi
Norges Bank Investment Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Bank of America Corporation
Legal & General Group
Citadel Advisors
Southpoint Capital Advisors
Earnest Partners
Point72 Asset Management
Millennium Management

View all funds holding Qiagen Nv